Go to deals
Private Equity | Healthcare

Cooper Consumer Health has sold Stardea to EA Pharma

Cooper Consumer Health has sold Stardea to EA Pharma.

Founded in 2005 and based in Italy, Stardea is a recognized player in the fields of nutraceuticals, medical devices and dermocosmetics. The company has 56 products characterized by quality, effectiveness and safety, including 47 complex food supplements. Stardea’s products are structured around nine functional areas: cardiovascular, neurological, breathing, metabolic, musculoskeletal, gastroenterology, urological, pediatric and dermatological. The company distributes its products to pharmacies through medical referrals, with a network of doctors covering a large part of the country and a team of medical representatives to promote its products.

With a history of more than 70 years, the EA Pharma group is a pharmaceutical laboratory and a major player in Europe in the field of natural health and nutrition products. EA Pharma is the pioneer and undisputed leader in oligotherapy and a major European producer of food supplements marketed under its umbrella brands Granions and Eafit in France and Drasanvi in Spain. The group also sells sports and health nutrition products and natural cosmetics.

Cooper Consumer Health is a leading independent European pure play self-care platform with more than 90% of its sales coming from OTC products and covering more than 30 OTC segments. Today, more than 80,000 pharmacists advise Cooper Consumer Health's self-care solutions.

Oaklins’ team in France supported Cooper Consumer Health on the sale of Stardea to EA Pharma. The team in Italy supported the transaction by facilitating the communication between the parties.

Parties

Talk to the deal team

Antoine Lemaire

Partner
Paris, France
Oaklins France

Giuseppe Maria Bernardo Puccio

Principal
Milan, Italy
Oaklins Italy

Charlotte Delphis

Associate Director
Paris, France
Oaklins France

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Private Equity | Business Support Services | Construction & Engineering Services

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.

Learn more
Nuzoa has acquired Agrofauna
Private Equity | Consumer & Retail

Nuzoa has acquired Agrofauna

Nuzoa, a provider of value-added services for pets and livestock in the Iberian Peninsula, has acquired 100% of Agrofauna. This transaction reinforces Nuzoa’s presence in the Portuguese market, particularly in the northern region, marking another step toward its ambition to become the leading operator while further consolidating its brand across Iberia.

Learn more